Poseida Therapeutics is a clinical-stage biopharmaceutical company leveraging their proprietary next-generation, non-viral gene engineering technologies to create life-saving cell and gene therapies for patients with high unmet medical need. They are using their broad gene engineering platform technologies to bring new and better treatments to patients with serious diseases — blood cancers like multiple myeloma, solid tumor cancers like prostate and breast cancer, and rare genetic diseases in the liver.
Poseida brings together scientists, entrepreneurs, and inventors united behind one goal: using advanced gene engineering to change how diseases are treated.